To keep you better informed about the biggest trends and developments affecting medication management, medication adherence, and clinical pharmacist services, here are some of the most significant news reports published in October. Highlights include stories on Star Ratings, health equity, deprescribing, and rising drug costs.
CMS issued a fact sheet summarizing changes to its 2023 Medicare Advantage and Part D Star Ratings.
A MedCity News column argued for providing more care at home to help address health equity and areas including medication reconciliation and care coordination.
Multiple research teams demonstrated that incorporating pharmacists into outpatient diabetes clinics can significantly improve key markers of disease progression.
A Pharmacy Today column took a deep dive into deprescribing, including at-risk populations, goals, barriers, and medication targets.
New reports illustrated the need to address rapidly increasing prescription drug costs that create affordability challenges.
Research found that among people with lupus, two important factors may play a role in persistent medication nonadherence: hurried interactions with healthcare providers and low self-efficacy.
A study revealed that self-measured blood pressure monitoring has minimal effect on blood pressure control, but when it's accompanied by co-interventions such as clinical support, it has several significant benefits.
With staffing shortages in skilled nursing homes creating medication management challenges, pharmacists are taking on expanded roles and responsibilities.
The American College of Cardiology (ACC) offered a comprehensive and integrative framework for treating patients with atherosclerotic cardiovascular disease (ASCVD) and multimorbidity.
A consensus update stated that diabetes self-management education and support is a key intervention in managing hyperglycemia in type 2 diabetes.